News

Stimulating Interactions

NEWS

Colleen Cutcliffe, Whole Biome

Improving human health by sequencing and analyzing the microbiome and developing targeted therapies Colleen Cutcliffe is co-founder and CEO of Whole Biome, a company working with the Mayo Clinic and others to analyze the microbiome—the community of microorganisms that lives on and in our bodies—and to develop therapies that use the microbiome to improve human health. Whole Biome, which has […]

Read more

Uri Lopatin, Assembly Biosciences

Targeting the hepatitis B virus Ramen to reverse merger in under two years. Uri Lopatin co-founded Assembly Pharmaceuticals in 2012, first working from home and then riding his bicycle to our incubator. At one point he literally ate ramen noodles for two months straight. But less than two years later, his startup merged with Ventrus Biosciences to form Assembly Biosciences, […]

Read more

MedGenome keen to team-up with state govts

MedGenome is looking to partner with the state governments in the country to offer its OncoMD, a cancer analytics platform with information on over 1.2 million cancer mutations allowing accurate interpretation of genomic variations. Currently in India there are cancer camps conducted in rural areas and district hospitals. In Karnataka the state government owned Kidwai Memorial Institute of Oncology has […]

Read more

Innovation in fixed-dose combos: HIV/AIDS therapeutics edition

The FDA has published guidance to support the submission process for companies developing fixed-dose combinations (FDCs) for the treatment of HIV patients. According to this guidance, “FDCs are essential for the treatment of HIV/AIDS…They are consistent with the goal of HIV therapy—to maximally and durably suppress virus to allow the recovery of the immune system and reduce the emergence of HIV resistance.” However, […]

Read more

It’s free! QB3 inks equipment donation deal for biomed startups

It’s free! QB3 inks equipment donation deal for biomed startups One of the lures of the University of California’s QB3 incubator network for life sciences startups is access to the same core facilities — centralized sites with million-dollar pieces of equipment — used by top-flight medical researchers. Now QB3 and partner American Laboratory Trading Inc. believe they’ve found a way […]

Read more
Page 8 of 8« First...45678

Upcoming Event

  • An Afternoon Tea Party for the Awesome 3 from the Magnificent 7!

    14:00-15:30
    08/31/2017
    1st Floor Conference Room, GEHC
    953 Indiana Street, San Francisco, CA 94107, United States
    RSVP From common-but-stubborn ailments like acne to the future of gene therapy or personalized cancer care, the breadth of biotech innovation happening in the Bay Area is vast. All told, the California Life Sciences Association estimates that the sector accounts for some 68,300 jobs in the region and nearly $1 billion in annual venture capital investment. To capture a snapshot of the work under way, the Business Times selected seven young scientists and entrepreneurs spanning established drugmakers, startups and academia. Though their interests and backgrounds are varied, they all have one thing in common: each is poised to make a major impact on the future of life sciences. Read the complete article at BizJournals

Address

953 Indiana St., San Francisco, CA 94107
Tel: (415)-347-8287
Map

Sign-Up for our Newsletter